Form 8-K - Current report:
SEC Accession No. 0001193125-20-149214
Filing Date
2020-05-22
Accepted
2020-05-22 06:10:56
Documents
3
Period of Report
2020-05-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d925586d8k.htm 8-K 24326
2 EX-1.1 d925586dex11.htm EX-1.1 242338
3 EX-5.1 d925586dex51.htm EX-5.1 5751
  Complete submission text file 0001193125-20-149214.txt   273551
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 20903570
SIC: 2834 Pharmaceutical Preparations